U.S. Venture Partners

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating neurological disorders. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation to address conditions such as tinnitus, chronic pain, and rehabilitation following strokes. Its flagship product, Vivistim, has received FDA approval for use in ischemic stroke survivors experiencing moderate to severe upper limb impairment. MicroTransponder's innovative approaches, which include paired vagus nerve stimulation and wireless neurostimulation systems, are designed to enhance recovery and improve quality of life for patients facing various neurological challenges.

Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.

Nervonik is a medical device company specializing in the development of an opioid-free peripheral nerve stimulation system. The company focuses on advancing its clinical research and achieving regulatory approvals for its innovative neuro-modulation device, which is designed for therapeutic applications. This miniaturized device employs sensing feedback to deliver closed-loop optimized therapy, allowing patients to receive targeted treatment for chronic disorders. Through its commitment to innovation, Nervonik aims to provide effective alternatives for pain management without reliance on opioids.

Delfina is a company that specializes in developing a personalized prenatal care system aimed at ensuring the safety of mothers and infants during pregnancy. By leveraging data and machine learning, Delfina's platform creates individualized pregnancy care plans that assess patient risk through various metrics. This approach not only enhances interventional workflows but also improves provider efficiency, facilitating early intervention in prenatal care. Delfina's commitment to data-driven insights is paving the way for clinical innovation, ultimately striving to deliver equitable and cost-effective healthcare solutions for expectant families.

Quantifind, Inc. is a data science company that specializes in creating on-demand insights platforms aimed at enhancing marketing effectiveness and detecting financial crimes such as money laundering and fraud. Founded in 2008 by two Ph.D. graduates in atomic physics, the company offers several key products, including signum Analysis, which helps users assess performance drivers for brands and competitors; signum Voice, which focuses on revenue drivers; and signum Impact, which measures the effects of sponsorships on brand awareness and sales. Additionally, Quantifind's platform integrates internal financial institution data with public domain data to identify risks, thereby assisting financial crime analysts in minimizing false positive alerts and managing risk. The company serves various sectors, including automotive, consumer packaged goods, entertainment, financial services, pharmaceuticals, retail, and telecommunications, and has established a strategic partnership with Oracle Financial Services. Quantifind is headquartered in Menlo Park, California, with additional offices in Silicon Valley, New York, and Washington, D.C.

Lightlytics specializes in cloud deployment technologies that assist SRE and DevOps teams in managing infrastructure updates and developments. The company provides a continuously updated model of cloud environments by tracking behavior and configuration changes. Its technology enables teams to automatically predict, pre-empt, and prevent potential failures, downtime, and business disruptions by simulating all possible dependencies and assessing their impact on operations prior to deployment. This capability allows organizations to code and deploy configurations efficiently and securely, ensuring smooth operations from code to cloud.

Okami Medical, Inc. is a manufacturer of medical devices specializing in the occlusion of peripheral vessels, primarily through its innovative LOw-profile Braided Occluder (LOBO) system. This device provides interventional physicians with a single solution for occluding various arterial targets, eliminating the need for multiple embolic devices. The LOBO incorporates proprietary HDBRAID technology, which features a unique pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011 and headquartered in Aliso Viejo, California, Okami Medical was established to meet the evolving needs of patients and healthcare providers by developing versatile and intuitive devices that ensure rapid and reliable vessel occlusion under diverse conditions.

ShiraTronics, Inc. is a company that specializes in developing and commercializing neuromodulation therapies aimed at treating chronic migraines, a condition that significantly impacts the lives of millions worldwide. Founded in 2018 and headquartered in Ireland, with an additional location in Minneapolis, Minnesota, ShiraTronics is focused on addressing unmet clinical needs in neurology. The company's innovative technologies offer new approaches to effectively alleviate the debilitating effects of migraine headaches, thereby striving to improve the quality of life for those affected by this disabling disorder.

Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.

Sepio has developed an innovative asset risk management platform focused on protecting organizations from hardware-based attacks. Unlike traditional methods that monitor asset activity, Sepio's solution uses physical layer asset DNA profiling to provide actionable visibility and control over hardware assets. This platform enables security teams to gain comprehensive insight into their infrastructure, regardless of whether it includes IT, OT, or IoT components. With trafficless monitoring, the solution reports the actual assets present within 24 hours, along with associated risk factors, allowing for effective policy enforcement and mitigation of rogue devices. By enabling administrators to define granular usage rules and continuously monitor their hardware assets, Sepio enhances cybersecurity posture and helps organizations manage their assets efficiently and securely.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for disorders related to corticosteroid excess. Founded in 2013 by David A. Katz and based in Portland, Oregon, the company aims to provide better therapeutic options for patients suffering from hypercortisolism and autoimmune or inflammatory conditions. By utilizing unique insights into corticosteroid biology, Sparrow is advancing its lead product, SPI-62, an oral small molecule treatment that specifically targets the source of active intracellular corticosteroids in critical tissues. This approach is designed to alleviate the adverse effects of both naturally occurring corticosteroids, such as cortisol due to tumors, and the long-term use of corticosteroid medications like prednisone.

Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

Cagent Vascular, LLC is a medical device company based in Wayne, Pennsylvania, focused on developing innovative solutions for cardiovascular diseases. The company specializes in angioplasty balloons that utilize proprietary serration technology to enhance treatment outcomes. Its flagship product, the Serranator, features serrated metal strips embedded in a semi-compliant balloon, designed specifically for the treatment of atherosclerosis and conditions such as peripheral artery disease and chronic limb-threatening ischemia. By employing a minimally invasive approach, Cagent Vascular aims to improve vessel dilatation during cardiovascular interventions, ultimately enhancing patient care and quality of life. Founded in 2014, the company is dedicated to advancing intravascular technology in the medical field.

IONIX specializes in attack surface management, offering a solution that identifies and monitors exploitable risks across a company's digital landscape and supply chain. Utilizing advanced machine learning, IONIX's platform discovers internet-facing assets and their connections, helping organizations to understand and prioritize critical vulnerabilities. The platform employs innovative detection techniques to uncover new assets and analyze their relationships, addressing the gap between traditional security measures and the tactics employed by modern attackers. Prominent companies such as Infosys, Warner Music Group, The Telegraph, and E.ON rely on IONIX for its comprehensive risk assessment and remediation tools, which empower them to proactively manage their security posture in an increasingly complex threat environment.

Zero Networks Inc., founded in 2019 and based in Tel Aviv, Israel, specializes in cloud-based network security software. The company focuses on automating the development and enforcement of network access rules, allowing organizations to customize access for users and machines based on their communication patterns. Its technology eliminates the need for agents or manual policy configurations, providing a streamlined security solution. Additionally, Zero Networks includes a two-factor authentication mechanism that allows for secure connectivity even in unusual situations, ensuring that legitimate connections remain unaffected. By automating network access policies, Zero Networks aims to enhance security and prevent breaches, thereby safeguarding organizational operations.

Stensul is an email generation platform designed to streamline the email creation process for enterprise marketers. By centralizing and pre-configuring the platform for each brand, Stensul eliminates the need for extensive collaboration with designers, developers, and quality assurance teams. This allows marketers to concentrate on crafting engaging content that drives results. The platform simplifies complex coding and design tasks, enabling marketing teams to produce mobile-responsive emails that adhere to brand and legal guidelines. With Stensul, businesses can efficiently build and send emails through their existing email service providers or marketing clouds, ultimately reducing production time and costs while enhancing communication effectiveness.

Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.

Darwinium specializes in developing a decision technology platform that integrates security, fraud prevention, and customer experience enhancements. The platform employs machine learning, orchestration, and analytics to protect mobile applications, websites, and APIs from sophisticated automated attacks. By utilizing techniques such as anonymization, masking, and secure computing, Darwinium safeguards customer privacy and reduces risk exposure. This comprehensive approach allows clients to enhance their revenue, minimize fraud losses, and mitigate bot activity effectively.

Luminopia is focused on developing innovative treatments for significant neuro-visual disorders, particularly amblyopia, commonly known as lazy eye, which is a leading cause of vision loss in children. The company is creating digital therapeutics that undergo rigorous evaluation for FDA approval while ensuring they are engaging for patients. In collaboration with Boston Children's Hospital, Luminopia is advancing its primary product, Luminopia One, which utilizes a binocular therapeutic approach to effectively address amblyopia. This development aims to enhance the capabilities of healthcare professionals in treating these critical vision disorders.

Trust Lab develops software for social media platforms that helps in detecting misinformation, hate speech, and harmful content.

Percepto is a developer of autonomous drone technology for inspection and surveillance. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the first deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring), the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Surgical Safety Technologies specializes in providing data-driven artificial intelligence technology to hospitals, aimed at enhancing surgical safety. The company’s platform offers an objective assessment of both technical and non-technical skills of surgeons, utilizing academically validated frameworks. By delivering descriptive, predictive, and prescriptive insights, the platform supports data-driven clinical and operational decisions, ultimately improving surgical quality and patient safety in healthcare settings.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.

Quantifind, Inc. is a data science company that specializes in creating on-demand insights platforms aimed at enhancing marketing effectiveness and detecting financial crimes such as money laundering and fraud. Founded in 2008 by two Ph.D. graduates in atomic physics, the company offers several key products, including signum Analysis, which helps users assess performance drivers for brands and competitors; signum Voice, which focuses on revenue drivers; and signum Impact, which measures the effects of sponsorships on brand awareness and sales. Additionally, Quantifind's platform integrates internal financial institution data with public domain data to identify risks, thereby assisting financial crime analysts in minimizing false positive alerts and managing risk. The company serves various sectors, including automotive, consumer packaged goods, entertainment, financial services, pharmaceuticals, retail, and telecommunications, and has established a strategic partnership with Oracle Financial Services. Quantifind is headquartered in Menlo Park, California, with additional offices in Silicon Valley, New York, and Washington, D.C.

HealthJoy, LLC operates an online healthcare decision platform that aims to reduce out-of-pocket expenses for consumers by enabling better healthcare decisions. Founded in 2014 and based in Chicago, the company focuses on enhancing the benefits experience for employees while assisting organizations in managing costs. Through personalized guidance and AI-driven technology, HealthJoy provides employees with a digital benefits wallet that integrates their existing benefits, ensuring they remain informed about their options. The platform offers on-demand access to online medical consultations, healthcare concierges, and prescription savings, empowering users to make educated choices about their healthcare. By simplifying the healthcare experience and offering insights into cost-effective care options, HealthJoy helps employees improve their satisfaction and reduces the burden on human resources.

Sepio has developed an innovative asset risk management platform focused on protecting organizations from hardware-based attacks. Unlike traditional methods that monitor asset activity, Sepio's solution uses physical layer asset DNA profiling to provide actionable visibility and control over hardware assets. This platform enables security teams to gain comprehensive insight into their infrastructure, regardless of whether it includes IT, OT, or IoT components. With trafficless monitoring, the solution reports the actual assets present within 24 hours, along with associated risk factors, allowing for effective policy enforcement and mitigation of rogue devices. By enabling administrators to define granular usage rules and continuously monitor their hardware assets, Sepio enhances cybersecurity posture and helps organizations manage their assets efficiently and securely.

SecuriThings, Inc. specializes in providing comprehensive security solutions for Internet of Things (IoT) devices, leveraging big data and machine learning to detect cyber threats in real time. Founded in 2015 and headquartered in Tel Aviv, with an additional office in New York, the company offers a range of services including physical security through video surveillance, access control, and intrusion detection, as well as IoT networks for smart cities and building automation. Its Horizon platform enhances operational efficiency and cybersecurity, delivering automation, analytics, and actionable alerts to ensure the secure operation of IoT devices. Trusted by Fortune 100 companies, SecuriThings has successfully implemented its solutions in large enterprises such as airports, universities, and hospitals. The company collaborates with system integrators and device manufacturers to provide robust insights and reliability in IoT security management.

Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers flexible payment options, allowing them to either rent or purchase items on a monthly subscription basis. This model enables individuals to create aesthetically pleasing living spaces without the burden of high upfront costs. Additionally, customers can enjoy a trial period before committing to a purchase, with the option of 0% interest financing, making home decoration both easy and affordable.

TaskHuman, Inc. operates an online platform that facilitates video coaching aimed at enhancing personal wellness. Founded in 2017 and based in Palo Alto, California, the platform connects users with a diverse network of coaches, including athletic trainers, life coaches, nutrition experts, yoga instructors, and specialists across various wellness domains. TaskHuman allows individuals to engage in real-time, one-on-one interactive sessions through video calls, addressing over 1,000 aspects of well-being, such as physical fitness, mental health, spiritual growth, and career development. The company aims to make self-care and personal wellness accessible and affordable, empowering users to improve their health and lifestyle through personalized coaching.

MicroTransponder, Inc. is a medical device company based in Austin, Texas, specializing in the development and commercialization of neurostimulation devices aimed at treating neurological disorders. Founded in 2007, the company focuses on therapies that utilize vagus nerve stimulation to address conditions such as tinnitus, chronic pain, and rehabilitation following strokes. Its flagship product, Vivistim, has received FDA approval for use in ischemic stroke survivors experiencing moderate to severe upper limb impairment. MicroTransponder's innovative approaches, which include paired vagus nerve stimulation and wireless neurostimulation systems, are designed to enhance recovery and improve quality of life for patients facing various neurological challenges.

Nfinite is a company that specializes in developing a cloud-based platform utilizing AI and 3D technology to enhance product visualization for brands and retailers. Founded in 2017 and based in the US and France, Nfinite offers a comprehensive suite of services that includes AI training and fine-tuning, leveraging high-quality synthetic data to customize AI models for specific industry needs. Its proprietary computer-generated imagery technology enables the creation of diverse visual content through virtual shooting, allowing retailers to replace traditional photographic images for online displays and catalogs. By providing limitless product visual experiences, Nfinite aims to improve sales and streamline the merchandising process for various sectors.

Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

IONIX specializes in attack surface management, offering a solution that identifies and monitors exploitable risks across a company's digital landscape and supply chain. Utilizing advanced machine learning, IONIX's platform discovers internet-facing assets and their connections, helping organizations to understand and prioritize critical vulnerabilities. The platform employs innovative detection techniques to uncover new assets and analyze their relationships, addressing the gap between traditional security measures and the tactics employed by modern attackers. Prominent companies such as Infosys, Warner Music Group, The Telegraph, and E.ON rely on IONIX for its comprehensive risk assessment and remediation tools, which empower them to proactively manage their security posture in an increasingly complex threat environment.

Kryptowire was jumpstarted by the Defense Advanced Research Projects Agency (DARPA) and the Department of Homeland Security (DHS S&T), and has been vetted by the US military, law enforcement, and intelligence agencies. Kryptowire provides mobile application security analysis tools, anti‐piracy technologies, mobile app marketplace security analytics, and Enterprise Mobility Management (EMM) solutions. Kryptowire was founded in 2011, is based in Fairfax, Virginia, and has a customer base ranging from government agencies to national cable TV companies.

Nfinite is a company that specializes in developing a cloud-based platform utilizing AI and 3D technology to enhance product visualization for brands and retailers. Founded in 2017 and based in the US and France, Nfinite offers a comprehensive suite of services that includes AI training and fine-tuning, leveraging high-quality synthetic data to customize AI models for specific industry needs. Its proprietary computer-generated imagery technology enables the creation of diverse visual content through virtual shooting, allowing retailers to replace traditional photographic images for online displays and catalogs. By providing limitless product visual experiences, Nfinite aims to improve sales and streamline the merchandising process for various sectors.

Hunters is a cybersecurity company that specializes in developing an artificial intelligence-based platform for detecting and responding to cyber threats. Founded in 2018 and headquartered in Tel Aviv, Israel, the company offers its solution, Hunters.AI, which autonomously identifies cyberattacks that may evade traditional security measures across various IT environments, including cloud and network systems. Hunters.AI integrates diverse security telemetry and intelligence, enriching threat signals with detailed tactics, techniques, and procedures to enhance detection capabilities. By utilizing machine learning and cloud-based analytics, the platform correlates threat patterns and generates high-fidelity attack narratives, enabling cybersecurity teams to respond swiftly and effectively to potential breaches.

Qnovo is a company focused on advancing lithium-ion battery technology through its innovative battery management software and predictive analytics. Established in 2010 and headquartered in Milpitas, California, Qnovo aims to enhance the performance and safety of electric vehicles, energy storage systems, and consumer devices. The company has developed a unique approach to battery charging that involves real-time measurement of battery health, allowing for faster charging and extended battery lifespan. With a portfolio of over 50 patents, Qnovo collaborates with leading automotive manufacturers and has its technology integrated into over 150 million smartphones globally. Its investors include prominent firms in the technology and climate sectors.

Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke management.

TaskHuman, Inc. operates an online platform that facilitates video coaching aimed at enhancing personal wellness. Founded in 2017 and based in Palo Alto, California, the platform connects users with a diverse network of coaches, including athletic trainers, life coaches, nutrition experts, yoga instructors, and specialists across various wellness domains. TaskHuman allows individuals to engage in real-time, one-on-one interactive sessions through video calls, addressing over 1,000 aspects of well-being, such as physical fitness, mental health, spiritual growth, and career development. The company aims to make self-care and personal wellness accessible and affordable, empowering users to improve their health and lifestyle through personalized coaching.

Luma Health Inc. is a San Francisco-based company that specializes in developing a patient engagement platform aimed at enhancing the connection between healthcare providers and patients. Founded in 2015, the platform facilitates smart scheduling and referral management while offering features such as appointment reminders, mobile patient intake, and care pathways. It enables healthcare systems and clinics to keep their schedules full and supports patient adherence to care plans. Additionally, Luma Health provides tools for patient communication and analytics, ensuring that healthcare providers can deliver continuous care and improve treatment outcomes. The company emphasizes a modern, mobile-first approach to patient engagement.

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company based in San Diego, California. Established in 2012, the company specializes in developing selective translation regulators for cancer and other serious diseases. Its innovative approach involves small molecule drugs known as selective translation regulator inhibitors (STRIs), which target the eIF4F complex and its associated kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). This complex plays a crucial role in the translation of specific messenger RNA into proteins linked to cancer progression. eFFECTOR's lead product candidate, tomivosertib, is currently being evaluated in a Phase 2b trial in combination with pembrolizumab for non-small cell lung cancer. Additionally, zotatifin, an inhibitor of eIF4A, is undergoing dose-escalation trials with plans for further expansion. The company also collaborates with Pfizer to develop inhibitors targeting eIF4E. Through these efforts, eFFECTOR aims to address the challenges of tumor growth, survival, and immune evasion in cancer treatment.

Hunters is a cybersecurity company that specializes in developing an artificial intelligence-based platform for detecting and responding to cyber threats. Founded in 2018 and headquartered in Tel Aviv, Israel, the company offers its solution, Hunters.AI, which autonomously identifies cyberattacks that may evade traditional security measures across various IT environments, including cloud and network systems. Hunters.AI integrates diverse security telemetry and intelligence, enriching threat signals with detailed tactics, techniques, and procedures to enhance detection capabilities. By utilizing machine learning and cloud-based analytics, the platform correlates threat patterns and generates high-fidelity attack narratives, enabling cybersecurity teams to respond swiftly and effectively to potential breaches.

Carrot Fertility, Inc. specializes in providing comprehensive fertility benefits services to employers, supporting employees throughout their fertility healthcare journey on a global scale. The company's offerings include services such as egg freezing, in vitro fertilization, adoption, donor and gestational carrier services, as well as a premium pharmacy experience for fertility medications through Carrot Rx. Additionally, Carrot Pregnancy provides virtual access to experts and on-demand doctor-approved content, while the Carrot Card allows employees to use a flexible debit card for their fertility-related expenses. By customizing these benefits, Carrot Fertility aims to deliver financial, medical, and emotional support for individuals pursuing parenthood. Founded in 2015 and headquartered in San Francisco, California, the company also maintains offices in Chicago, New York, Dublin, Geneva, Tokyo, and Seoul.

Human Interest is a 401(k) provider that simplifies retirement savings for small and medium-sized businesses. Founded in 2015 in San Francisco by Paul Sawaya and Roger Lee, the company developed an end-to-end technology platform that addresses administrative and compliance challenges associated with retirement plans. This platform automatically creates employee accounts and syncs deductions with payroll providers, ensuring a streamlined process. In addition to facilitating employee retirement accounts, Human Interest offers personalized investment advice, enabling businesses to provide their employees with effective financial security solutions. The company has successfully assisted thousands of businesses across the United States in establishing accessible and affordable retirement plans.

Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing novel cancer therapies that target monoPARP proteins, which are essential regulators of cancer survival mechanisms. Established in 2015, Ribon is leveraging insights from its scientific founders and an experienced management team to create a proprietary drug discovery platform aimed at understanding the molecular actions and biological functions of monoPARPs. This platform enables the development of small molecule inhibitors designed to disrupt cancer cells' abilities to withstand stress, potentially leading to innovative treatments for cancer and other diseases. The company is supported by notable life science investors, positioning it for growth in the biopharmaceutical sector.

Standard Bariatrics is a medical device company based in Cincinnati, Ohio, founded in 2014. The company specializes in developing surgical instruments designed specifically for weight-loss surgeries, particularly laparoscopic sleeve gastrectomy. One of its key products, the Standard Clamp, enables surgeons to standardize their techniques, thereby reducing variation and improving efficiency during procedures. The company’s tools are intended to be used alongside general-use endoscopic staplers with reloadable cartridges, which helps to minimize the number of cartridges required for each surgery. This innovation not only lowers costs for healthcare providers but also assists in creating consistent surgical outcomes.

Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers flexible payment options, allowing them to either rent or purchase items on a monthly subscription basis. This model enables individuals to create aesthetically pleasing living spaces without the burden of high upfront costs. Additionally, customers can enjoy a trial period before committing to a purchase, with the option of 0% interest financing, making home decoration both easy and affordable.

Informed, Inc. is a technology company based in San Francisco, California, established in 2016. It operates a platform designed to facilitate the connection between buyers and sellers of pre-owned cars while also providing services that enhance the digital transformation of banks. The company offers a robotic process automation solution that performs essential verification tasks, including income, identity, residence, and insurance verifications. This automation helps banks minimize manual costs related to document reviews, mitigate fraud, reduce bias, and decrease errors during loan origination and account opening processes. Additionally, Informed's consumer auto financing platform features a digital assistant that gathers necessary documents from borrowers and employs machine learning and optical character recognition to streamline and automate the loan origination process for auto lenders.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for disorders related to corticosteroid excess. Founded in 2013 by David A. Katz and based in Portland, Oregon, the company aims to provide better therapeutic options for patients suffering from hypercortisolism and autoimmune or inflammatory conditions. By utilizing unique insights into corticosteroid biology, Sparrow is advancing its lead product, SPI-62, an oral small molecule treatment that specifically targets the source of active intracellular corticosteroids in critical tissues. This approach is designed to alleviate the adverse effects of both naturally occurring corticosteroids, such as cortisol due to tumors, and the long-term use of corticosteroid medications like prednisone.

AirEye specializes in wireless security solutions aimed at protecting organizational networks from airborne attacks that exploit wireless communications such as Wi-Fi, cellular, 5G, and Bluetooth. Its flagship product, AirEye Dome, provides comprehensive monitoring and real-time protection against unauthorized network access, data leaks, and other security threats. The platform detects and blocks violations automatically, integrating seamlessly with existing network security infrastructures without requiring major architectural changes. By offering complete visibility and control over wireless activity, including employee hotspots and dual-connected devices, AirEye enables organizations to safeguard their IT and operational technology assets effectively. The solution is utilized across various sectors, including finance, healthcare, manufacturing, and aerospace, ensuring robust security against advanced persistent threats.

Territory Foods is a meal delivery service that focuses on providing chef-prepared, nutritionist-approved meals tailored to various dietary preferences. Established in 2011 and headquartered in Arlington, VA, the company offers a diverse range of freshly-made meals designed by culinary professionals and nutrition experts. Its menus feature artisan dishes that are responsibly sourced and free of refined sugars, gluten, and dairy, catering to health-conscious consumers. Meals can be customized to fit dietary needs such as Vegan, Vegetarian, Whole30, and Keto, making it easier for customers to maintain healthy eating habits. Territory Foods employs a proprietary algorithm to ensure a rotating menu that keeps meal options varied and engaging.

Dapper Labs Inc., founded in 2018 and based in Vancouver, Canada, specializes in developing blockchain-based gaming platforms and collectibles. The company is best known for NBA Top Shot, which utilizes blockchain technology to facilitate non-fungible tokens (NFTs) and enhance digital engagement for sports fans. Dapper Labs focuses on creating immersive experiences that allow consumers to connect more intimately with their favorite brands, fostering vibrant communities and enabling fans to actively participate in content creation. Its innovative approach offers users secure ownership and new avenues for digital interaction, positioning Dapper Labs as a leader in the intersection of entertainment and blockchain technology.

Dapper Labs Inc., founded in 2018 and based in Vancouver, Canada, specializes in developing blockchain-based gaming platforms and collectibles. The company is best known for NBA Top Shot, which utilizes blockchain technology to facilitate non-fungible tokens (NFTs) and enhance digital engagement for sports fans. Dapper Labs focuses on creating immersive experiences that allow consumers to connect more intimately with their favorite brands, fostering vibrant communities and enabling fans to actively participate in content creation. Its innovative approach offers users secure ownership and new avenues for digital interaction, positioning Dapper Labs as a leader in the intersection of entertainment and blockchain technology.

Act-On Software, Inc. is a developer of a cloud-based marketing automation platform tailored for small and mid-sized businesses. The platform enables marketers to create and manage various marketing campaigns, including email marketing, website lead generation, social media marketing, and account-based marketing. Act-On's solutions help organizations attract prospects, convert leads, and measure campaign effectiveness while enhancing customer engagement and brand awareness. Additionally, the company offers professional consulting, support, and training services to optimize the use of its platform. Act-On serves diverse industries such as banking, insurance, manufacturing, technology, and agencies. Founded in 2006 and headquartered in Portland, Oregon, Act-On also has locations in Scottsdale, Arizona, and Reading, United Kingdom.

Neuros Medical, Inc. is a neuromodulation company based in Willoughby Hills, Ohio, that specializes in developing proprietary neurostimulation therapies aimed at addressing unmet medical needs for patients globally. The company's flagship technology, known as Electrical Nerve Block, targets chronic pain conditions, including neuroma and residual limb pain, chronic post-surgical pain, and chronic migraine. Neuros Medical also offers the Neuros Altius System, which features an implantable generator with an integrated rechargeable battery, a cuff electrode, and associated external devices. Established in 2008, the company is dedicated to advancing innovative solutions for pain management.

Carlsmed is a medical technology company based in San Diego, California, specializing in spine surgery solutions. Founded in 2018, the company has developed the aprevo™ implant system, which is the first surgical implant designated as a breakthrough technology by the FDA. This innovative 3-D printed implant system offers personalized medicine benefits specifically for lumbar fusion surgery. Carlsmed employs machine learning technologies and analysis of prior outcomes data to enhance the treatment of complex adult spinal deformities, aiming to improve surgical outcomes and reduce healthcare costs associated with spine surgery. The company serves hospitals and surgeons nationwide, providing advanced solutions for adult spinal malalignment.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company based in Boulder, Colorado, that specializes in developing small molecule therapies for severe, rare musculoskeletal diseases. Founded in 2017, the company employs a precision medicine approach to create innovative treatments targeting various muscle disorders, including Duchenne and Becker muscular dystrophies, as well as limb girdle muscular dystrophies. Utilizing its proprietary muscle-focused drug discovery platform, Edgewise integrates expertise in muscle biology and small molecule engineering to identify and develop therapies that address genetically defined muscle disorders. The company emphasizes a holistic drug discovery method that assesses integrated muscle function, enabling it to create orally bioavailable therapies aimed at improving outcomes for patients with significant unmet medical needs in neuromuscular and cardiac diseases.

Percepto is a developer of autonomous drone technology for inspection and surveillance. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the first deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring), the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Stensul is an email generation platform designed to streamline the email creation process for enterprise marketers. By centralizing and pre-configuring the platform for each brand, Stensul eliminates the need for extensive collaboration with designers, developers, and quality assurance teams. This allows marketers to concentrate on crafting engaging content that drives results. The platform simplifies complex coding and design tasks, enabling marketing teams to produce mobile-responsive emails that adhere to brand and legal guidelines. With Stensul, businesses can efficiently build and send emails through their existing email service providers or marketing clouds, ultimately reducing production time and costs while enhancing communication effectiveness.

Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed a Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical challenge of reliable fixation for glenoid implants. This technology not only enhances post-surgical implant stability, reducing the risk of revision surgeries, but also simplifies surgical instrumentation, which can lead to shorter operative times and lower costs. Shoulder Innovations markets its products through distribution partners across the United States, aiming to improve patient care and reduce overall healthcare costs.

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, that specializes in developing tissue-targeted therapeutics aimed at treating cancer, chronic viral infections, and other serious diseases. The company’s lead product candidate, SBT6050, is currently undergoing a Phase I/Ib clinical trial; it is a TLR8 agonist conjugated to a HER2-directed monoclonal antibody, targeting tumors such as breast, gastric, and non-small cell lung cancers. Additionally, Silverback is advancing SBT6290, which is in preclinical development and targets Nectin4, found in bladder, triple-negative breast, head and neck, and non-small cell lung cancers. The company is also developing SBT8230, aimed at treating chronic hepatitis B virus infection, and exploring other agents that utilize its proprietary technology to modulate pathways in oncology and fibrosis indications. Silverback's innovative ImmunoTAC platform enables the design of therapies that are systemically delivered but act specifically at disease sites, unlocking previously inaccessible pathways for treatment.

Medigate by Claroty is a developer of a medical device security platform that safeguards healthcare provider networks from cyber threats. Founded in 2017, the company is headquartered in New York City and focuses on protecting all connected medical devices within these networks. Its platform utilizes deep packet inspection to decode proprietary healthcare IoT protocols, providing visibility and security for IoT and medical devices. By offering threat detection and attack prevention services, Medigate enhances the safety and privacy of hospital environments, allowing for the secure deployment of both existing and new medical devices.

Optimize Health is a digital healthcare provider specializing in remote patient monitoring (RPM) solutions. The company offers a user-friendly platform that incorporates both equipment and software designed to streamline the implementation of RPM programs. Its software aids healthcare providers in complying with Medicare billing requirements for RPM services while ensuring a positive experience for both patients and providers. The platform automatically tracks medication doses and sends reminders to users, leveraging Bluetooth technology to sync with smartphones and tablets. This approach empowers patients to manage their health effectively and enables physicians to achieve profitability from RPM services starting in the first month.

Carrot Fertility, Inc. specializes in providing comprehensive fertility benefits services to employers, supporting employees throughout their fertility healthcare journey on a global scale. The company's offerings include services such as egg freezing, in vitro fertilization, adoption, donor and gestational carrier services, as well as a premium pharmacy experience for fertility medications through Carrot Rx. Additionally, Carrot Pregnancy provides virtual access to experts and on-demand doctor-approved content, while the Carrot Card allows employees to use a flexible debit card for their fertility-related expenses. By customizing these benefits, Carrot Fertility aims to deliver financial, medical, and emotional support for individuals pursuing parenthood. Founded in 2015 and headquartered in San Francisco, California, the company also maintains offices in Chicago, New York, Dublin, Geneva, Tokyo, and Seoul.

Hunters is a cybersecurity company that specializes in developing an artificial intelligence-based platform for detecting and responding to cyber threats. Founded in 2018 and headquartered in Tel Aviv, Israel, the company offers its solution, Hunters.AI, which autonomously identifies cyberattacks that may evade traditional security measures across various IT environments, including cloud and network systems. Hunters.AI integrates diverse security telemetry and intelligence, enriching threat signals with detailed tactics, techniques, and procedures to enhance detection capabilities. By utilizing machine learning and cloud-based analytics, the platform correlates threat patterns and generates high-fidelity attack narratives, enabling cybersecurity teams to respond swiftly and effectively to potential breaches.

Okami Medical, Inc. is a manufacturer of medical devices specializing in the occlusion of peripheral vessels, primarily through its innovative LOw-profile Braided Occluder (LOBO) system. This device provides interventional physicians with a single solution for occluding various arterial targets, eliminating the need for multiple embolic devices. The LOBO incorporates proprietary HDBRAID technology, which features a unique pore structure that effectively reduces blood flow and accelerates vessel closure. Founded in 2011 and headquartered in Aliso Viejo, California, Okami Medical was established to meet the evolving needs of patients and healthcare providers by developing versatile and intuitive devices that ensure rapid and reliable vessel occlusion under diverse conditions.

Zerto Ltd. specializes in disaster recovery and business continuity software for virtualized data centers and cloud environments. Founded in 2009 and headquartered in Boston, Massachusetts, the company offers the Zerto Cloud Continuity Platform, which includes its flagship product, Zerto Virtual Replication. This software enables organizations to protect, recover, and migrate applications across public, private, and hybrid clouds. Zerto's solutions are designed to simplify the complexities associated with modernization and cloud adoption, making it easier for enterprises to maintain continuous operations. The company's products are utilized in various applications, including Oracle, SAP, and SQL server replication and recovery, serving industries such as healthcare, legal, and finance. Zerto operates globally, with offices in locations including Israel, Japan, the United Kingdom, India, Canada, Mexico, and Brazil.

Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform that integrates networking and security solutions for enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations such as California, the United Kingdom, Singapore, Hong Kong, and Australia, the company offers a secure global SD-WAN. Cato's platform connects various enterprise locations, personnel, and data while optimizing application access across all users and locations. Key features include WAN optimization, firewall protection, secure web gateways, and threat protection. Cato Networks enables organizations to reduce costs associated with MPLS, improve performance for global locations and cloud applications, and eliminate the need for branch appliances, all while providing secure internet access and integrating mobile users and cloud data centers into the network seamlessly.

Forager Logistics LLC, established in 2018 and based in Chicago, Illinois, specializes in freight brokerage and logistics services for the automotive and aerospace industries. The company offers a range of truckload services, including standard, expedited, and cross-border transportation, catering to supply chain networks with seamless and modern solutions. Forager's innovative web-based transportation management platform further enhances its service, targeting the complexities of cross-border shipping, particularly to and from Mexico and Canada.

Arkose Labs, based in San Francisco, California, develops a cybersecurity platform aimed at preventing online fraud and abuse for various industries, including online marketplaces, travel, banking, social media, ticketing, and gaming. Established in 2015, the company offers solutions to combat issues such as account takeover, fake account abuse, scraping, spam, and gift card fraud. Arkose Labs employs an AI-powered system that combines risk assessments with dynamic threat responses, effectively mitigating attacks while enhancing legitimate user experiences. The platform is recognized for its effectiveness, having received accolades for customer satisfaction and market presence. Additionally, it provides unique warranties against credential stuffing and SMS toll fraud, further demonstrating its commitment to protecting businesses from cybercrime. With a significant portion of its clientele being Fortune 500 companies, Arkose Labs operates offices in major locations, including Brisbane, Australia, and has established a strong reputation in the cybersecurity landscape.

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, that specializes in developing tissue-targeted therapeutics aimed at treating cancer, chronic viral infections, and other serious diseases. The company’s lead product candidate, SBT6050, is currently undergoing a Phase I/Ib clinical trial; it is a TLR8 agonist conjugated to a HER2-directed monoclonal antibody, targeting tumors such as breast, gastric, and non-small cell lung cancers. Additionally, Silverback is advancing SBT6290, which is in preclinical development and targets Nectin4, found in bladder, triple-negative breast, head and neck, and non-small cell lung cancers. The company is also developing SBT8230, aimed at treating chronic hepatitis B virus infection, and exploring other agents that utilize its proprietary technology to modulate pathways in oncology and fibrosis indications. Silverback's innovative ImmunoTAC platform enables the design of therapies that are systemically delivered but act specifically at disease sites, unlocking previously inaccessible pathways for treatment.

HealthJoy, LLC operates an online healthcare decision platform that aims to reduce out-of-pocket expenses for consumers by enabling better healthcare decisions. Founded in 2014 and based in Chicago, the company focuses on enhancing the benefits experience for employees while assisting organizations in managing costs. Through personalized guidance and AI-driven technology, HealthJoy provides employees with a digital benefits wallet that integrates their existing benefits, ensuring they remain informed about their options. The platform offers on-demand access to online medical consultations, healthcare concierges, and prescription savings, empowering users to make educated choices about their healthcare. By simplifying the healthcare experience and offering insights into cost-effective care options, HealthJoy helps employees improve their satisfaction and reduces the burden on human resources.

Epsagon Ltd. is a developer of solutions designed for monitoring serverless architecture systems. Founded in 2017 and headquartered in Tel Aviv, Israel, the company provides a SaaS platform that enables development and operations teams to enhance their efficiency by automating data correlation and offering end-to-end observability within microservice environments. Epsagon's lightweight agent SDK allows for automated instrumentation and tracing, ensuring comprehensive visibility across various cloud resources, including containers and virtual machines, without requiring extensive training or manual coding. By predicting performance issues before they arise and facilitating quicker problem resolution, Epsagon helps organizations optimize costs and reduce application downtime, ultimately streamlining the deployment of new features and improving overall operational effectiveness.

ShiraTronics, Inc. is a company that specializes in developing and commercializing neuromodulation therapies aimed at treating chronic migraines, a condition that significantly impacts the lives of millions worldwide. Founded in 2018 and headquartered in Ireland, with an additional location in Minneapolis, Minnesota, ShiraTronics is focused on addressing unmet clinical needs in neurology. The company's innovative technologies offer new approaches to effectively alleviate the debilitating effects of migraine headaches, thereby striving to improve the quality of life for those affected by this disabling disorder.

Kenna Security, Inc. is a technology company that specializes in vulnerability management and risk intelligence solutions. Founded in 2009 and headquartered in San Francisco, with an additional office in Chicago, Kenna offers a platform that helps organizations prioritize vulnerabilities, assess risks, and automate their analysis. This platform leverages Cyber Risk Context Technology to measure and predict cyber risks, enabling security teams to focus on the most critical issues. Kenna serves a diverse range of sectors, including media, healthcare, telecommunications, financial services, and transportation, both in the United States and internationally. With a customer base that includes many Fortune 100 companies, Kenna's solutions facilitate cross-functional collaboration to proactively address cyber threats and enhance overall security efficacy.

Primary makes clothes for kids and builds a better experience for busy parents to shop for them. It aims to be the most inclusive kid's clothing brand, offering high-quality essentials at affordable prices. Rather than chasing the trend, Primary offers thoughtfully designed clothing without logos, slogans, or sequins. They take a gender-neutral approach, with a broad range of colors available for babies and kids 0-12, without prescribing what is for girls or boys. It was founded in 2015 and is headquartered in New York, New York.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company based in Boulder, Colorado, that specializes in developing small molecule therapies for severe, rare musculoskeletal diseases. Founded in 2017, the company employs a precision medicine approach to create innovative treatments targeting various muscle disorders, including Duchenne and Becker muscular dystrophies, as well as limb girdle muscular dystrophies. Utilizing its proprietary muscle-focused drug discovery platform, Edgewise integrates expertise in muscle biology and small molecule engineering to identify and develop therapies that address genetically defined muscle disorders. The company emphasizes a holistic drug discovery method that assesses integrated muscle function, enabling it to create orally bioavailable therapies aimed at improving outcomes for patients with significant unmet medical needs in neuromuscular and cardiac diseases.

Luma Health Inc. is a San Francisco-based company that specializes in developing a patient engagement platform aimed at enhancing the connection between healthcare providers and patients. Founded in 2015, the platform facilitates smart scheduling and referral management while offering features such as appointment reminders, mobile patient intake, and care pathways. It enables healthcare systems and clinics to keep their schedules full and supports patient adherence to care plans. Additionally, Luma Health provides tools for patient communication and analytics, ensuring that healthcare providers can deliver continuous care and improve treatment outcomes. The company emphasizes a modern, mobile-first approach to patient engagement.

Entelo is a recruitment platform that leverages data science and machine learning to assist companies in identifying and recruiting technical talent. Its SaaS-based solution enables talent acquisition teams to automatically rank and screen applicants using directed scoring technologies, thereby enhancing key metrics such as quality of hire, time to hire, and cost per hire. With over 600 customers across various industries, Entelo provides actionable insights and increases candidate engagement, making it a trusted partner for organizations aiming to improve their recruitment processes. Notable clients include prominent companies like Capital One, Cisco, and Netflix, which utilize Entelo's capabilities to build effective teams.

Rimeto LLC, founded in 2016 and based in San Francisco, California, provides software solutions that enhance workplace collaboration through detailed employee directories and profiles. As a subsidiary of Slack Technologies, Rimeto specializes in integrating data from various enterprise systems to create a people-centric platform that simplifies access to information within organizations. By leveraging both public and proprietary data, Rimeto enables clients to build customized directories that facilitate project tracking and improve communication among teams. The company's mission is to empower employees by making information easily accessible and actionable, ultimately fostering a more connected and collaborative work environment.

Human Interest is a 401(k) provider that simplifies retirement savings for small and medium-sized businesses. Founded in 2015 in San Francisco by Paul Sawaya and Roger Lee, the company developed an end-to-end technology platform that addresses administrative and compliance challenges associated with retirement plans. This platform automatically creates employee accounts and syncs deductions with payroll providers, ensuring a streamlined process. In addition to facilitating employee retirement accounts, Human Interest offers personalized investment advice, enabling businesses to provide their employees with effective financial security solutions. The company has successfully assisted thousands of businesses across the United States in establishing accessible and affordable retirement plans.

Cleave Therapeutics, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2010. The company specializes in developing novel small-molecule drugs that target valosin-containing protein and other protein-degradation pathways critical for the survival of cancer cells. By focusing on these mechanisms, Cleave Therapeutics aims to create enzyme inhibitors that can effectively treat cancer and neurodegenerative diseases. Its research efforts are directed toward discovering innovative therapies that may improve patient outcomes in oncology.

Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Dstillery, Inc. is a digital intelligence platform based in New York that specializes in developing marketing solutions for brands and media partners. Founded in 2008, the company offers a range of services aimed at enhancing brand awareness, consideration, and customer retention. Dstillery's platform utilizes artificial intelligence to capture mobile location insights and integrate them with desktop behaviors, thereby optimizing advertising across mobile, desktop, and video channels. The company is recognized for its innovative technology, including its patented ID-free® behavioral targeting, which provides privacy-safe ad targeting that reaches all ad impressions. Dstillery also offers Custom AI Audiences, a targeting solution that refreshes user data regularly to ensure optimal campaign performance. The company primarily serves clients within the United States and has earned numerous patents for its advanced technologies that facilitate effective audience engagement and maximize marketing effectiveness.

Percepto is a developer of autonomous drone technology for inspection and surveillance. The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data. Leveraging its experience with Percepto Sparrow, the first deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring), the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.

Happy Returns, Inc. is a company that specializes in providing in-person return solutions for online shoppers. Founded in 2015 and headquartered in Santa Monica, California, it operates a network of Return Bars where customers can return items in person and receive immediate refunds. The company handles the logistics of shipping returned items back to e-commerce retailers, thereby streamlining the return process for both consumers and businesses. By integrating technology and service, Happy Returns aims to offer a seamless return experience that meets the needs of shoppers while also providing retailers with cost-effective logistics solutions.

HealthJoy, LLC operates an online healthcare decision platform that aims to reduce out-of-pocket expenses for consumers by enabling better healthcare decisions. Founded in 2014 and based in Chicago, the company focuses on enhancing the benefits experience for employees while assisting organizations in managing costs. Through personalized guidance and AI-driven technology, HealthJoy provides employees with a digital benefits wallet that integrates their existing benefits, ensuring they remain informed about their options. The platform offers on-demand access to online medical consultations, healthcare concierges, and prescription savings, empowering users to make educated choices about their healthcare. By simplifying the healthcare experience and offering insights into cost-effective care options, HealthJoy helps employees improve their satisfaction and reduces the burden on human resources.

Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform that integrates networking and security solutions for enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations such as California, the United Kingdom, Singapore, Hong Kong, and Australia, the company offers a secure global SD-WAN. Cato's platform connects various enterprise locations, personnel, and data while optimizing application access across all users and locations. Key features include WAN optimization, firewall protection, secure web gateways, and threat protection. Cato Networks enables organizations to reduce costs associated with MPLS, improve performance for global locations and cloud applications, and eliminate the need for branch appliances, all while providing secure internet access and integrating mobile users and cloud data centers into the network seamlessly.

Medigate by Claroty is a developer of a medical device security platform that safeguards healthcare provider networks from cyber threats. Founded in 2017, the company is headquartered in New York City and focuses on protecting all connected medical devices within these networks. Its platform utilizes deep packet inspection to decode proprietary healthcare IoT protocols, providing visibility and security for IoT and medical devices. By offering threat detection and attack prevention services, Medigate enhances the safety and privacy of hospital environments, allowing for the secure deployment of both existing and new medical devices.

HighLife is a medical technology company specializing in Transcatheter Mitral Valve Replacement (TMVR) aimed at treating patients with mitral valve regurgitation. Co-founded in 2010 by Georg Börtlein, the company is developing a minimally invasive prosthetic mitral valve that can be implanted in a beating heart while preserving the native valve structure and surrounding anatomy. The innovative system allows for delivery through a transseptal passage via the femoral vein, enabling a reversible procedure that minimizes patient trauma during complex heart surgeries. HighLife's focus is on ensuring ease and safety of use, contributing to improved treatment outcomes for patients. The company's technology is currently undergoing clinical evaluation.

Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, focused on developing novel cancer therapies that target monoPARP proteins, which are essential regulators of cancer survival mechanisms. Established in 2015, Ribon is leveraging insights from its scientific founders and an experienced management team to create a proprietary drug discovery platform aimed at understanding the molecular actions and biological functions of monoPARPs. This platform enables the development of small molecule inhibitors designed to disrupt cancer cells' abilities to withstand stress, potentially leading to innovative treatments for cancer and other diseases. The company is supported by notable life science investors, positioning it for growth in the biopharmaceutical sector.

NeoChord, Inc. is a medical technology company based in St. Louis Park, Minnesota, that focuses on developing innovative devices for the treatment of degenerative mitral valve disease (DMR). Founded in 2007, the company has created the NeoChord Artificial Chordae Delivery System, a disposable device designed for minimally invasive mitral valve repair. This system allows surgeons to replace damaged chordae through a small incision of 2 to 3 inches between the ribs, enabling the procedure to be performed on a beating heart. This approach contrasts sharply with traditional methods, which typically involve larger incisions and stopping the heart, thus reducing recovery time and associated complications. NeoChord's technology aims to improve surgical outcomes for patients suffering from severe mitral regurgitation, which can lead to serious conditions such as atrial fibrillation and congestive heart failure.

ZypMedia, Inc., also known as ZypTV, operates a demand-side platform that connects advertisers with audiences on streaming television. Founded in 2013 and headquartered in San Francisco, the company has expanded to include offices in New York City, New Delhi, and Saint Petersburg. ZypMedia offers products like ZypTV Enterprise and ZypTV Self-Serve, tailored for local streaming TV advertising. The platform is designed for local media companies, media buying agencies, and brands seeking to effectively target local audiences at scale. By integrating machine learning with human expertise, ZypMedia provides tools that facilitate the transition between traditional and digital advertising, enabling clients to enhance their offerings and increase revenue in a rapidly evolving media landscape.

Arkose Labs, based in San Francisco, California, develops a cybersecurity platform aimed at preventing online fraud and abuse for various industries, including online marketplaces, travel, banking, social media, ticketing, and gaming. Established in 2015, the company offers solutions to combat issues such as account takeover, fake account abuse, scraping, spam, and gift card fraud. Arkose Labs employs an AI-powered system that combines risk assessments with dynamic threat responses, effectively mitigating attacks while enhancing legitimate user experiences. The platform is recognized for its effectiveness, having received accolades for customer satisfaction and market presence. Additionally, it provides unique warranties against credential stuffing and SMS toll fraud, further demonstrating its commitment to protecting businesses from cybercrime. With a significant portion of its clientele being Fortune 500 companies, Arkose Labs operates offices in major locations, including Brisbane, Australia, and has established a strong reputation in the cybersecurity landscape.

Raken, Inc. develops a construction management software that enhances field and office workflows for the construction industry. Founded in 2012 and based in Carlsbad, California, Raken offers a mobile-first platform that includes features such as daily reports, time cards, production tracking, and toolbox talks. This software enables general, trade, concrete, electrical, excavating, and mechanical contractors to efficiently manage various construction-related tasks, including accident documentation, subcontractor information, site safety, project photos, weather conditions, and equipment rentals. Raken's technology streamlines communication between the field and office, allowing superintendents, foremen, and project managers to quickly record and submit essential reports and documentation. The platform is utilized by numerous leading contractors and subcontractors in the industry.

Luma Health Inc. is a San Francisco-based company that specializes in developing a patient engagement platform aimed at enhancing the connection between healthcare providers and patients. Founded in 2015, the platform facilitates smart scheduling and referral management while offering features such as appointment reminders, mobile patient intake, and care pathways. It enables healthcare systems and clinics to keep their schedules full and supports patient adherence to care plans. Additionally, Luma Health provides tools for patient communication and analytics, ensuring that healthcare providers can deliver continuous care and improve treatment outcomes. The company emphasizes a modern, mobile-first approach to patient engagement.

Inari Medical, Inc. is a commercial-stage medical device company based in Irvine, California, that specializes in developing innovative products for the treatment of venous diseases. Founded in 2011, the company's primary focus is on venous thromboembolism, which it addresses through two key devices: the ClotTriever and the FlowTriever. The ClotTriever is designed for the minimally invasive removal of blood clots from peripheral blood vessels, specifically targeting patients with deep vein thrombosis. Meanwhile, the FlowTriever system effectively treats pulmonary embolism by removing large clots from major blood vessels without the need for thrombolytic drugs. Inari Medical primarily generates its revenue from the United States while also reaching international markets.